Advanced search
Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 35, 2011 - Issue 3
Submit an article Journal homepage
206
Views
18
CrossRef citations to date
0
Altmetric
PROCEEDINGS 19th ICOC November 2009, London, UK

Sequential Alternating Deferiprone And Deferoxamine Treatment Compared To Deferiprone Monotherapy: Main Findings And Clinical Follow-Up Of A Large Multicenter Randomized Clinical Trial In -Thalassemia Major Patients

Gaetano Restivo PantaloneUnità Operativa Complessa Ematologia II con Talassemia, Azienda Ospedaliera Ospedali Riuniti Villa Sofia, Vincenzo Cervello, Palermo, ItaliaCorrespondence[email protected]
,
Aurelio MaggioUnità Operativa Complessa Ematologia II con Talassemia, Azienda Ospedaliera Ospedali Riuniti Villa Sofia, Vincenzo Cervello, Palermo, Italia
,
Angela VitranoUnità Operativa Complessa Ematologia II con Talassemia, Azienda Ospedaliera Ospedali Riuniti Villa Sofia, Vincenzo Cervello, Palermo, Italia
,
Marcello CapraUnità Operativa Complessa VII Pediatria per le Emopatie Ereditarie, Centro di Prevenzione Diagnosi e Cura della Talassemia, Azienda Ospedaliera Giuseppe Di Cristina, Palermo, Italia
,
Liana CucciaUnità Operativa Complessa VII Pediatria per le Emopatie Ereditarie, Centro di Prevenzione Diagnosi e Cura della Talassemia, Azienda Ospedaliera Giuseppe Di Cristina, Palermo, Italia
,
Francesco GagliardottoUnità Operativa Complessa VII Pediatria per le Emopatie Ereditarie, Centro di Prevenzione Diagnosi e Cura della Talassemia, Azienda Ospedaliera Giuseppe Di Cristina, Palermo, Italia
,
Aldo FilosaUnità Operativa Complessa Pediatria, Azienda Ospedaliera Cardarelli, Napoli, Italia
,
Maria Antonietta RomeoUnità Operativa Complessa Talassemia, Clinica Pediatrica I Università degli Studi di Catania, Azienda Ospedaliera Policlinico, Catania, Italia
,
Carmelo MagnanoUnità Operativa Dipartimentale Talassemia, Presidio Ospedaliera San Luigi-Currò, Azienda Ospedaliera Garibaldi, Catania, Italia
,
Vincenzo CarusoUnità Operativa Dipartimentale Talassemia, Presidio Ospedaliera San Luigi-Currò, Azienda Ospedaliera Garibaldi, Catania, Italia
,
Crocetta ArgentoUnità Operativa Complessa Medicina Trasfusionale, Azienda Ospedaliera San Giovanni di Dio, Agrigento, Italia
,
Calogera GerardiUnità Operativa Semplice di Talassemia, Presidio Ospedaliero Giovanni Pauloo II, Sciacca, Italia
,
Saveria CampisiUnità Operativa Semplice Centro Microcitemia, Azienda Ospedaliera Umberto I, Siracusa, Italia
,
Pietro VioliCasa Sollievo della Sofferenza, Istituto di Ricovero e Cura a Carattere Scientifico, Unità Operativa Centro della Microcitemia, San Giovanni Rotondo, Foggia, Italia
,
Roberto MaliziaUnità Operativa Complessa Pediatria II, Azienda Ospedaliera Ospedali Riuniti Villa Sofia, Vincenzo Cervello, Palermo, Italia
,
Paolo CianciulliUnità Operativa Talassemia, Azienda Ospedaliera San Eugenio, Roma, Italia
,
Michele RizzoUnità Operativa Complessa Ematologia, Azienda Ospedaliera San Elia, Caltanissetta, Italia
,
Domenico Giuseppe D’AscolaCentro Microcitemia, Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italia
,
Alessandra QuotaUnità Operativa Complessa Medicina Trasfusionale Azienda Ospedaliera Vittorio Emanuele III, Gela, Italia
,
Luciano ProssomaritiCentro Regionale per la Cura delle Microcitemie, Azienda Ospedaliera Cardarelli, Napoli, Italia
,
Carmelo FidoneUnità Operativa Complessa Centro Trasfusionale, Azienda Ospedaliera Maria Paternò Arezzo, Ragusa, Italia
,
Paolo RiganoUnità Operativa Complessa Ematologia II con Talassemia, Azienda Ospedaliera Ospedali Riuniti Villa Sofia, Vincenzo Cervello, Palermo, Italia
,
Alessia PepeIstituto di Fisiologia Clinica Consiglio Nazionale delle Ricerche, Pisa, Italia
,
Gennaro D’AmicoUnità Operativa Complessa Gastroenterologia, Azienda Ospedaliera Ospedali Riuniti Villa Sofia, Vincezo Cervello, Palermo, Italia
,
Alberto MorabitoIstituto Giulio Alfredo Maccacaro, Università di Milano, Milano, Italia
&
Christian GluudCopenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
 show all
Pages 206-216 | Published online: 20 May 2011

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Richa Shah, Aashaka Shah & Sherif M. Badawy. (2023) An evaluation of deferiprone as twice-a-day tablets or in combination therapy for the treatment of transfusional iron overload in thalassemia syndromes. Expert Review of Hematology 16:2, pages 81-94.
Read now
Adriana Ceci, Rosa Conte, Antonella Didio, Donato Bonifazi, Mariagrazia Felisi, Viviana Giannuzzi & Fedele Bonifazi. (2019) An overview of the efficacy and safety of deferiprone in paediatric patients with congenital haemoglobinopathies and chronic iron overload. Expert Opinion on Orphan Drugs 7:4, pages 181-197.
Read now
Kevin H.M. Kuo & Marko Mrkobrada. (2014) A Systematic Review and Meta-Analysis of Deferiprone Monotherapy and in Combination with Deferoxamine for Reduction of Iron Overload in Chronically Transfused Patients with β-Thalassemia. Hemoglobin 38:6, pages 409-421.
Read now

Articles from other publishers (15)

Louise J Geneen, Carolyn Dorée & Lise J Estcourt. (2023) Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia. Cochrane Database of Systematic Reviews 2023:3.
Crossref
Christine C. Hsu, Nizar H. Senussi, Kleber Y. Fertrin & Kris V. Kowdley. (2022) Iron overload disorders. Hepatology Communications 6:8, pages 1842-1854.
Crossref
Andrew Binding, Richard Ward, George Tomlinson & Kevin H. M. Kuo. (2019) Deferiprone exerts a dose‐dependent reduction of liver iron in adults with iron overload. European Journal of Haematology 103:2, pages 80-87.
Crossref
Nancy F. Olivieri, Amir Sabouhanian & Brenda L. Gallie. (2019) Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox. PLOS ONE 14:2, pages e0211942.
Crossref
Patricia M Fortin, Sheila A Fisher, Karen V Madgwick, Marialena Trivella, Sally Hopewell, Carolyn Doree & Lise J Estcourt. (2018) Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia. Cochrane Database of Systematic Reviews 2018:5.
Crossref
Robert Crichton. 2016. Iron Metabolism. Iron Metabolism 376 417 .
Somayeh Kalanaky, Maryam Hafizi, Sepideh Safari, Kazem Mousavizadeh, Mahboubeh Kabiri, Alireza Farsinejad, Saideh Fakharzadeh & Mohammad Hassan Nazaran. (2016) TLc-A, the leading nanochelating-based nanochelator, reduces iron overload in vitro and in vivo. International Journal of Hematology 103:3, pages 274-282.
Crossref
Raffaella Origa. (2014) Combination Therapies in Iron Chelation. Thalassemia Reports 4:3, pages 4862.
Crossref
Maria Marsella & Caterina Borgna-Pignatti. (2014) Transfusional Iron Overload and Iron Chelation Therapy in Thalassemia Major and Sickle Cell Disease. Hematology/Oncology Clinics of North America 28:4, pages 703-727.
Crossref
Vip Viprakasit & Worapant Kriengsoontornkij. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions 419 433 .
Sujian Xia, Weidong Zhang, Liting Huang & Hong Jiang. (2013) Comparative Efficacy and Safety of Deferoxamine, Deferiprone and Deferasirox on Severe Thalassemia: A Meta-Analysis of 16 Randomized Controlled Trials. PLoS ONE 8:12, pages e82662.
Crossref
Sheila A Fisher, Susan J Brunskill, Carolyn Doree, Onima Chowdhury, Sarah Gooding & David J Roberts. (2013) Oral deferiprone for iron chelation in people with thalassaemia. Cochrane Database of Systematic Reviews.
Crossref
Sheila A Fisher, Susan J Brunskill, Carolyn Doree, Sarah Gooding, Onima Chowdhury & David J Roberts. (2013) Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia. Cochrane Database of Systematic Reviews.
Crossref
Dennis J. Cada, Terri L. Levien & Danial E. Baker. (2012) Deferiprone. Hospital Pharmacy 47:2, pages 129-136.
Crossref
V. S. Nadarajan. (2011) Modern management of thalassemia. ISBT Science Series 6:2, pages 432-437.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.